Steven Cohen’s Anterix ATEX Stock Holding History

Steven Cohen’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$319K	Buy	+3,100	New	+$182K	﹤0.01%	3359

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Steven Cohen's ATEX Position: Q1 2025 in Review

Steven Cohen sold out of Anterix (ATEX) in Q1 2025, closing a stake of 2,630 shares — an estimated $80.7K sold.

Steven Cohen first reported a position in ATEX in Q2 2020 and held it in 3 quarters. The position peaked at $1.09M in Q3 2020. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

Steven Cohen reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
Steven Cohen sold 2,630 Anterix shares in Q1 2025, an estimated $80.7K.
Steven Cohen first reported a position in Anterix in Q2 2020 and held it in 3 quarters.
Steven Cohen's Anterix position peaked at $1.09M in Q3 2020.
128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.